Lundbeck
HLUN-B.CO
#2722
Rank
HK$50.88 B
Marketcap
HK$51.28
Share price
0.19%
Change (1 day)
22.81%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2026 (TTM): HK$6.68 Billion

According to Lundbeck's latest financial reports the company's current earnings are HK$4.00 Billion. In 2025 the company made an earning of HK$5.96 Billion, an increase over its 2024 earnings that were of HK$4.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$6.68 B12.03%
2025 HK$5.96 B37.43%
2024 HK$4.34 B25.74%
2023 HK$3.45 B21.77%
2022 HK$2.83 B31.57%
2021 HK$2.15 B-4.61%
2020 HK$2.25 B-45.06%
2019 HK$4.11 B-34.04%
2018 HK$6.23 B12.83%
2017 HK$5.52 B93.99%
2016 HK$2.84 B-137.28%
2015 -HK$7.65 Billion-1246.24%
2014 HK$0.66 B-72.36%
2013 HK$2.41 B4.38%
2012 HK$2.31 B-55.18%
2011 HK$5.15 B5.65%
2010 HK$4.88 B-5.9%
2009 HK$5.18 B